minoxidil has been researched along with tretinoin in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 11 (34.38) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Antoniou, AI; Athanassopoulos, CM; Cassar, A; Gatt, L; Magoulas, GE; Papaioannou, D; Schembri-Wismayer, P; Stoica, S; Suleiman, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Lavrijsen, AP; Vermeer, BJ | 1 |
| DeVillez, RL | 1 |
| Albers, SE; Fenske, NA | 1 |
| Hart, LL; London-Wong, DM | 1 |
| Ferry, JJ; Forbes, KK; Szpunar, GJ; VanderLugt, JT | 1 |
| Arndt, KA; Dover, JS | 1 |
| Baran, R | 1 |
| Neher, JO | 1 |
| Jorizzo, JL | 1 |
| Bazzano, GS; Galen, W; Terezakis, N | 1 |
| Dunn, CL; James, WD; Walsh, DS | 1 |
| Fisher, AA | 1 |
| Rand, S | 1 |
| Bergfeld, WF | 1 |
| Chung, JH; Eun, HC; Han, JH; Kim, KH; Kwon, OS; Lee, SR; Oh, YJ; Pyo, HK | 1 |
| Eun, HC; Kim, KH; Kwon, OS; Lee, SH; Shin, HS; Won, CH | 1 |
| Avram, MR; Rogers, NE | 1 |
| Dhurat, RS; Jerajani, HR; Melkote, S; Palav, A | 1 |
| Ascierto, PA; Capuano, A; Di Girolamo, F; Montesarchio, G; Vozza, A; Vozza, G | 1 |
| Ghanaat, M | 1 |
| Choi, SY; Hong, CK; Kim, BJ; Kim, MN; No, YA | 1 |
| Agrawal, S; Chen, G; Dhurat, R; Goren, A; Kovacevic, M; McCoy, J; Sharma, A; Sinclair, R; Situm, M; Tan, Y; Trüeb, RM; Vañó-Galván, S | 1 |
| Khunt, D; Kochar, P; Misra, M; Nayak, K; Polaka, S; Thakkar, S | 1 |
5 review(s) available for minoxidil and tretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The therapeutic use of topical minoxidil.
Topics: Administration, Cutaneous; Alopecia Areata; Drug Therapy, Combination; Female; Humans; Male; Minoxidil; Tretinoin | 1990 |
Cosmetic modalities for aging skin: what to tell patients.
Topics: Aged; Alopecia; Collagen; Cryosurgery; Dermabrasion; Humans; Minoxidil; Skin Aging; Skin Diseases; Tretinoin | 1990 |
Medical treatments for male and female pattern hair loss.
Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin | 2008 |
Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism.
Topics: Alopecia; Androgens; Dermatologic Agents; Drugs, Investigational; Female; Finasteride; Humans; Male; Minoxidil; Off-Label Use; Phototherapy; Tretinoin | 2010 |
3 trial(s) available for minoxidil and tretinoin
| Article | Year |
|---|---|
Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution.
Topics: Administration, Cutaneous; Adult; Biopsy, Needle; Body Water; Humans; Male; Middle Aged; Minoxidil; Permeability; Random Allocation; Skin; Skin Absorption; Solutions; Tretinoin | 1990 |
Topical tretinoin for hair growth promotion.
Topics: Administration, Topical; Adult; Alopecia; Drug Combinations; Female; Hair; Humans; Male; Middle Aged; Minoxidil; Stimulation, Chemical; Tretinoin | 1986 |
Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Topics: Administration, Topical; Adult; Alopecia; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Hair; Humans; Male; Middle Aged; Minoxidil; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Tretinoin | 2007 |
24 other study(ies) available for minoxidil and tretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis of minoxidil conjugates and their evaluation as HL-60 differentiation agents.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Differentiation; Cell Proliferation; Fluorenes; HL-60 Cells; Humans; Imidazoles; Minoxidil; Polyamines; Spermine | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Cosmetics and drugs. Is there a need for a third group: cosmeceutics?
Topics: Alopecia; Cosmetics; Dermatologic Agents; Humans; Minoxidil; Nonprescription Drugs; Photosensitivity Disorders; Skin Diseases; Tretinoin | 1991 |
Minoxidil with tretinoin in baldness.
Topics: Alopecia; Humans; Male; Minoxidil; Tretinoin | 1990 |
Dermatology.
Topics: Alopecia; Dermatology; Female; Humans; Male; Minoxidil; Skin; Syphilis; Tretinoin | 1989 |
Explosive eruption of pyogenic granuloma on the scalp due to topical combination therapy of minoxidil and retinoic acid.
Topics: Alopecia; Drug Combinations; Hemangioma; Humans; Male; Middle Aged; Minoxidil; Scalp; Skin Neoplasms; Tretinoin | 1989 |
Cosmetics by prescription.
Topics: Alopecia; Cosmetics; Drug Prescriptions; Humans; Minoxidil; Physicians, Family; Self Concept; Tretinoin | 1989 |
Bald scalps and wrinkles.
Topics: Aging; Alopecia; Humans; Minoxidil; Skin; Tretinoin | 1989 |
Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Alopecia; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Finasteride; Humans; Keratolytic Agents; Male; Minoxidil; Oxidoreductases; Pharmaceutical Vehicles; Tretinoin; Vasodilator Agents | 1995 |
Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
Topics: Drug Eruptions; Erythema; Granuloma; Humans; Male; Middle Aged; Minoxidil; Scalp Dermatoses; Tretinoin | 1993 |
Hair growth therapy(ies) for androgenetic alopecia.
Topics: Alopecia; Finasteride; Hair; Humans; Minoxidil; Tretinoin | 1996 |
Retinoids and hair growth.
Topics: Alopecia; Animals; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Keratolytic Agents; Male; Minoxidil; Retinoids; Tretinoin; Vasodilator Agents | 1998 |
Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro.
Topics: Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Hair; Humans; Keratolytic Agents; Minoxidil; Tretinoin | 2007 |
Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin.
Topics: Administration, Topical; Alopecia; Child; Dermatologic Agents; Drug Therapy, Combination; Ectodermal Dysplasia; Hair; Humans; Male; Minoxidil; Tretinoin | 2009 |
Kerion Celsi favored by the use of a tretinoin+minoxidil+betamethasone valerate lotion in a 28-year-old woman.
Topics: Adult; Alopecia Areata; Betamethasone; Drug Therapy, Combination; Female; Humans; Minoxidil; Tinea Capitis; Tretinoin | 2010 |
Topical minoxidil and tretinoin combined with an oral vitamin D analog as a treatment for woolly hair.
Topics: Administration, Cutaneous; Administration, Oral; Child; Child, Preschool; Dietary Supplements; Drug Therapy, Combination; Female; Hair; Hair Diseases; Humans; Hydroxycholecalciferols; Minoxidil; Treatment Outcome; Tretinoin | 2016 |
Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
Topics: Administration, Topical; Adult; Alopecia; Female; Gene Expression Regulation, Enzymologic; Humans; Male; Minoxidil; Sulfotransferases; Tretinoin; Up-Regulation | 2019 |
Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia.
Topics: Administration, Topical; Alopecia; Animals; Biological Transport; Drug Therapy, Combination; Hydrogels; Keratolytic Agents; Liposomes; Male; Minoxidil; Rats; Rats, Sprague-Dawley; Skin; Skin Diseases; Tretinoin; Vasodilator Agents | 2020 |